From July 8 to 10, the inaugural LEAP East International Technology and Information Exhibition was held at the Hong Kong Convention and Exhibition Centre. The event brought together over 400 exhibitors, more than 250 investors, and over 35,000 attendees, with technology leaders, industry experts, and startups from more than 30 countries and regions around the world gathering for this grand occasion. Eieling Technology showcased its complete POCT solution for fat quantification and fibrosis assessment at the exhibition, engaging with all parties to explore innovative directions for early liver disease screening.
Dual-Product Portfolio, Precisely Addressing Industry Pain Points
Eieling Technology has always been committed to the liver health sector, dedicated to providing portable, intelligent, and precise diagnostic solutions worldwide. Currently, traditional liver biopsy is an invasive procedure with inherent risks; large transient elastography devices, due to high costs and site limitations, are difficult to deploy widely in primary care and daily monitoring. As the prevalence of fatty liver disease, liver fibrosis, and other liver conditions continues to rise, the demand for non-invasive, convenient, and repeatable solutions is becoming increasingly urgent.
Leveraging its strong research and development capabilities, Eieling Technology has doubled the efficiency of traditional liver testing while significantly lowering operational barriers — no specialized ultrasound physicians are required, and operators can become proficient after short-term training. This advantage quickly captured the attention of numerous professional visitors at the exhibition.
Liverscan® — Portable Liver Elastography Ultrasound Diagnostic System
Liverscan® integrates transient elastography with real-time B-mode ultrasound image guidance into a single probe. Targeting the clinical challenge of detecting abdominal obesity patients, the device is equipped with four AI deep learning models and achieves a sampling volume 32 times that of traditional technology, enabling precise quantification of liver stiffness and steatosis. With just 4 valid measurements, the full assessment is completed, significantly improving detection efficiency while maximizing the avoidance of operator bias.
FattaLab® — Fatty Liver Diagnostic Device
Meanwhile, FattaLab® also became a focal point at the booth. As the world’s first palm-sized intelligent fatty liver assessment system, FattaLab® weighs only 120 grams and is powered by the proprietary Auto Intra-Focus Fusion (AIFF) liver fat detection algorithm. Through AI-automated liver region identification, it enables painless, non-invasive rapid detection in just 30 seconds. Its lightweight design and streamlined operation are precisely tailored for core scenarios including clinics, pharmaceutical companies, pharmacies, and screening centers, effectively reducing screening costs while greatly improving detection efficiency — providing a truly deployable solution for large-scale early screening and daily health management.
Multi-Party Collaboration and Dialogue, Charting the Blueprint for Liver Health Screening
Throughout the exhibition, the Eieling Technology booth drew a steady stream of visitors, with distributors, medical group representatives, and health management platform leaders from the Middle East, Southeast Asia, and other regions stopping by for in-depth discussions, resulting in multiple preliminary cooperation agreements reached on-site.
At LEAP East, Eieling Technology demonstrated to global industry partners the robust strength of China-originated liver health assessment technology. Liverscan® and FattaLab® together form a complete closed loop for liver health screening — from precise quantification to risk stratification, transforming every test into earlier intervention and more reliable protection. Looking ahead, Eieling Technology will continue to collaborate with global industry partners, grounded in core technology, to empower full-scenario liver health management upgrades, bringing precise, portable, and intelligent liver diagnostic solutions to more people and jointly building a new global ecosystem for liver health screening.